Kiniksa(KNSA) - 2024 Q2 - Quarterly Results

ARCALYST (IL-1α and IL-1β cytokine trap) 1 Abiprubart (anti-CD40 monoclonal antibody inhibitor of CD40-CD154 interaction) Financial Results Financial Guidance 2 · Kiniksa will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, July 23, 2024, to discuss second quarter 2024 financial results and recent portfolio execution. · Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email ...